Ubiquitin–proteasome system as a target for anticancer treatment—an update

YJ Kim, Y Lee, H Shin, SA Hwang, J Park… - Archives of pharmacal …, 2023 - Springer
As the ubiquitin–proteasome system (UPS) regulates almost every biological process, the
dysregulation or aberrant expression of the UPS components causes many pathological …

[HTML][HTML] Epigenetic modification regulates tumor progression and metastasis through EMT

T Tan, P Shi, MN Abbas, Y Wang… - International …, 2022 - spandidos-publications.com
Epigenetics is the study of heritable molecular determinants that are independent of
phenotypic features. The epigenetic features include DNA methylation, histone …

[HTML][HTML] The FOXM1/RNF26/p57 axis regulates the cell cycle to promote the aggressiveness of bladder cancer

L Yi, H Wang, W Li, K Ye, W Xiong, H Yu, X Jin - Cell death & disease, 2021 - nature.com
Bladder cancer is one of the most lethal cancers in the world. Despite the continuous
development of medical technologies and therapeutic strategies, the overall survival rate of …

Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR …

Z Li, Y Jiang, J Liu, H Fu, Q Yang… - … Journal of Oncology, 2023 - spandidos-publications.com
Bladder cancer (BC) is a heterogeneous disease, and pyrroline‑5‑carboxylate reductase 1
(PYCR1) can promote the proliferation and invasion of BC cells and accelerate BC …

[HTML][HTML] E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies

M Wang, Z Zhang, Z Li, Y Zhu, C Xu - Frontiers in Immunology, 2023 - frontiersin.org
With the rapidly increasing incidence of bladder cancer in China and worldwide, great efforts
have been made to understand the detailed mechanism of bladder cancer tumorigenesis …

DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer

Y Li, Y Zhou, M Huang, Z Wang, D Liu, J Liu, X Fu… - Cellular signalling, 2023 - Elsevier
Bladder cancer (BCa) is a common malignancy with uncertain molecular mechanism. 7-
dehydrocholesterol reductase (DHCR7), the enzyme of mammalian sterol biosynthesis …

Tumor cell-derived exosome RNF126 affects the immune microenvironment and promotes nasopharyngeal carcinoma progression by regulating PTEN ubiquitination

C Yu, B Xue, J Li, Q Zhang - Apoptosis, 2022 - Springer
This study aimed to investigate the role and regulatory mechanism of RNF126 in
nasopharyngeal carcinoma. Firstly, the expression and prognosis of RNF126 were analyzed …

Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions

M Hashemi, HZ Arani, S Orouei, E Rostamnejad… - Pharmacological …, 2022 - Elsevier
Urological cancers are considered as life-threatening diseases around the world. Bladder
cancer is one of the most malignant urological tumors with high mortality and morbidity …

[HTML][HTML] The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy

X Wang, Y Zhang, Y Wu, H Cheng, X Wang - Frontiers in Immunology, 2023 - frontiersin.org
Bladder cancer is one of the common malignant urothelial tumors. Post-translational
modification (PTMs), including ubiquitination, acetylation, methylation, and phosphorylation …

miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers

AS Sahib, A Fawzi, RS Zabibah, NA Koka, SA Khudair… - Cellular …, 2023 - Elsevier
The metastasis a major hallmark of tumors that its significant is not only related to the basic
research, but clinical investigations have revealed that majority of cancer deaths are due to …